Roche Holding AG buy phonebroker
Start price
30.01.12
/
50%
€136.35
Target price
18.04.12
€160.00
Performance (%)
8.62%
End price
18.04.12
€142.47
Summary
This prediction ended on 18.04.12 with a price of €142.47. With a performance of 8.62%, the BUY prediction by phonebroker for Roche Holding AG closed with a slight gain. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Roche Holding AG | - | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
Comments by phonebroker for this prediction
In the thread Roche Holding AG diskutieren
US-Zulassung fuer Hautkrebsmittel
FDA hat Zulassung fuer Erivedge zu Hautkrebsbehandlung erteilt.
Euro am Sonntag stuft den Titel als verlaesslichen Dividendenzahler, mit Aussicht auf Kurssteigerung ein.
(Vom Mitglied beendet)